T8	Treatment 102 111	flutamide
T9	Effect 52 95	decrease in prostate-specific antigen (PSA)
T10	Subject 128 200	subset of patients with progressing metastatic carcinoma of the prostate
T11	Sub-Disorder 152 200	progressing metastatic carcinoma of the prostate
T12	Drug 102 111	flutamide
